Health
Health News
Lantern Pharma to Host Virtual KOL Event on the Potential Treatment of Pancreatic Cancer with Drug Candidate LP-184 on November 18th, World Pancreatic Cancer Day
Lantern Pharma to Host Virtual KOL Event on the Potential Treatment of Pancreatic Cancer with Drug Candidate LP-184 on November...
Read more“Patient and Caregiver Guide to Bladder Cancer” segment to run on The Balancing Act® airing on Lifetime®
"Patient and Caregiver Guide to Bladder Cancer" segment to run on The Balancing Act® airing on Lifetime® PR Newswire PRINCETON,...
Read moreNxt-ID, Inc. Announces Third Quarter and Nine-Month 2021 Financial and Operational Results
Nxt-ID, Inc. Announces Third Quarter and Nine-Month 2021 Financial and Operational Results PR Newswire LOUISVILLE, Ky., Nov. 12, 2021 LOUISVILLE,...
Read moreData Presentation Today at The Liver Meeting® 2021 Shows Increasing Hospital Admissions for Alcohol-Associated Hepatitis (AH) in the U.S.
Data Presentation Today at The Liver Meeting® 2021 Shows Increasing Hospital Admissions for Alcohol-Associated Hepatitis (AH) in the U.S. AH...
Read moreAbbott’s New Leadless Pacemaker System Meets Primary Endpoints in Pivotal Trial
Abbott's New Leadless Pacemaker System Meets Primary Endpoints in Pivotal Trial -- New, late-breaking data from the Leadless II IDE...
Read moreInspira to Present at the H.C. Wainwright 7th Annual Israel Virtual Conference
Inspira to Present at the H.C. Wainwright 7th Annual Israel Virtual Conference PR Newswire RA'ANANA, Israel, Nov. 12, 2021 RA'ANANA,...
Read moreCorbus Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Updates
Corbus Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Updates - Company continues to advance integrin program from...
Read moreMoleculin Biotech, Inc to Present at the Virtual Investor Roundtable Event
Moleculin Biotech, Inc to Present at the Virtual Investor Roundtable Event - Live moderated video webcast discussion among members of...
Read moreActinium Presents First Ever Data with a CD47 Immunotherapy in Combination with a HER2-Directed Targeted Radiotherapy in Solid Tumors at the Society for Immunotherapy for Cancer (SITC) Conference
Actinium Presents First Ever Data with a CD47 Immunotherapy in Combination with a HER2-Directed Targeted Radiotherapy in Solid Tumors at...
Read moreEmmaus Life Sciences Reports Third Quarter Financial Results and Business Highlights
Emmaus Life Sciences Reports Third Quarter Financial Results and Business Highlights -- Net Revenues Increased 4% for the Nine Months...
Read more